Detalhe da pesquisa
1.
Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study.
BMC Immunol
; 24(1): 45, 2023 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974069
2.
Examination of autoantibodies to type I interferon in patients suffering from long COVID.
J Med Virol
; 95(9): e29089, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698062
3.
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
J Virol
; 93(8)2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700598
4.
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.
Clin Infect Dis
; 64(12): 1686-1695, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329286
5.
High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial.
Lancet Reg Health Eur
; 24: 100539, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36337437
6.
Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1.
iScience
; 26(9): 107628, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664600
7.
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.
Nat Med
; 29(10): 2547-2558, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696935
8.
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy.
Front Cell Infect Microbiol
; 12: 919097, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35865810
9.
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.
Open Forum Infect Dis
; 8(7): ofab295, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258320
10.
The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection.
J Interferon Cytokine Res
; 41(11): 407-414, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788130
11.
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
EBioMedicine
; 68: 103410, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098342
12.
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses.
EBioMedicine
; 64: 103230, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33530000
13.
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals.
AIDS
; 33(8): 1315-1325, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30932955
14.
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes.
EBioMedicine
; 45: 328-340, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31300344
15.
Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
AIDS Res Hum Retroviruses
; 28(11): 1404-11, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22867119